Figure 1. The clinical segmentation of the T1Gd abnormality (Top, orange line) is used to define the clinical target volume (CTV, white dashed line) as a 2 cm expansion of the segmentation. In clinical settings, 60 Gy is prescribed to the CTV. We propose to personalize the prescription dose (Bottom) to account for tumor infiltration and segmentation uncertainty.
...read more